Literature DB >> 7064714

Functional importance of nucleus accumbens noradrenaline in the rat.

L Svensson, S Ahlenius.   

Abstract

l-Noradrenaline. HCI (l-NA), d-noradrenaline.HCI(d-NA) and dopamine.HCI (DA)were locally applied in the nucleus accumbens of awake rats. When the animals were observed in a dark open field arena it was found that low doses of l-NA or DA produced suppression of ambulatory activity followed by an increase in the activity at higher doses. l-NA was more potent than DA in producing these effects and about 4 times higher doses of DA were required to produce the same effect. d-NA was not without effects but was less efficient than DA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7064714     DOI: 10.1111/j.1600-0773.1982.tb00934.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  4 in total

1.  Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson's disease.

Authors:  Kinga Kamińska; Tomasz Lenda; Jolanta Konieczny; Elżbieta Lorenc-Koci
Journal:  Psychopharmacology (Berl)       Date:  2022-09-30       Impact factor: 4.415

2.  Antagonism by haloperidol of the suppression of exploratory locomotor activity induced by the local application of (-)3-(3-hydroxyphenyl)-N-n-propylpiperidine into the nucleus accumbens of the rat.

Authors:  S Ahlenius; L Svensson; V Hillegaart; O Thorberg
Journal:  Experientia       Date:  1984-08-15

3.  Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain.

Authors:  K S Rommelfanger; D A Mitrano; Y Smith; D Weinshenker
Journal:  Neuroscience       Date:  2008-11-17       Impact factor: 3.590

4.  The effects of locus coeruleus and norepinephrine in methamphetamine toxicity.

Authors:  Michela Ferrucci; Filippo S Giorgi; Alessia Bartalucci; Carla L Busceti; Francesco Fornai
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.